Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Emery

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|May 30, 1998
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV diseaseD Gor, C Sabin, H G Prentice, et al.
HIV Medicine|December 12, 2001
Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replicationS Worrell, J Deayton, P Hayes, et al.
Journal of Medical Virology|July 27, 1999
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapyE F Bowen, J M Cherrington, P D Lamy, et al.
Lancet (London, England)|December 23, 1995
Natural history of untreated cytomegalovirus retinitisE F Bowen, P Wilson, M Atkins, et al.
FEBS Letters|September 4, 1995
Beta-sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopyC G Ullman, P I Haris, K F Smith, et al.
Lancet (London, England)|July 8, 2000
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantationV C Emery, C A Sabin, A V Cope, et al.
The Journal of Infectious Diseases|January 7, 1998
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupP D Griffiths, J E Feinberg, J Fry, et al.
Virology|April 1, 1989
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virusK Takehara, M K Min, J K Battles, et al.
Journal of Medical Virology|September 29, 1999
Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patientsM Grzywacz, J R Deayton, E F Bowen, et al.
British Journal of Cancer|March 1, 1993
Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear reportP J Bavin, J A Giles, A Deery, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|May 30, 1998
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV diseaseD Gor, C Sabin, H G Prentice, et al.
HIV Medicine|December 12, 2001
Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replicationS Worrell, J Deayton, P Hayes, et al.
Journal of Medical Virology|July 27, 1999
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapyE F Bowen, J M Cherrington, P D Lamy, et al.
Lancet (London, England)|December 23, 1995
Natural history of untreated cytomegalovirus retinitisE F Bowen, P Wilson, M Atkins, et al.
FEBS Letters|September 4, 1995
Beta-sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopyC G Ullman, P I Haris, K F Smith, et al.
Lancet (London, England)|July 8, 2000
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantationV C Emery, C A Sabin, A V Cope, et al.
The Journal of Infectious Diseases|January 7, 1998
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupP D Griffiths, J E Feinberg, J Fry, et al.
Virology|April 1, 1989
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virusK Takehara, M K Min, J K Battles, et al.
Journal of Medical Virology|September 29, 1999
Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patientsM Grzywacz, J R Deayton, E F Bowen, et al.
British Journal of Cancer|March 1, 1993
Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear reportP J Bavin, J A Giles, A Deery, et al.
Pageof 12